reports
Nokia Oyj: Omien osakkeiden takaisinosto 03.05.2024
Nokia Oyj: Omien osakkeiden takaisinosto 03.05.2024 Nokia OyjPörssitiedote03.05.2024 klo 22.30 Nokia Oyj: Omien osakkeiden takaisinosto 03.05.2024 Espoo – Nokia Oyj (LEI: 549300A0JPRWG1KI7U06) on 03.05.2024 hankkinut omia osakkeitaan (ISIN FI0009000681) omistukseensa seuraavasti: Markkinapaikka (MIC Code)Osakkeiden lukumääräPainotettu keskihinta osakkeelta, euroa*XHEL379 8083,44CEUX--BATE--AQEU--TQEX--Yhteensä379 8083,44 * Kahden desimaalin tarkkuuteen pyöristettynä Nokia ilmoitti 25. tammikuuta 2024, että yhtiön hallitus on käynnistämässä osakkeidensa takaisinosto-ohjelman palauttaakse...
Nokia Corporation: Repurchase of own shares on 03.05.2024
Nokia Corporation: Repurchase of own shares on 03.05.2024 Nokia CorporationStock Exchange Release03 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 03.05.2024 Espoo, Finland – On 03 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL379,8083.44CEUX--BATE--AQEU--TQEX--Total379,8083.44 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to...
- Jerôme Bodin
LR LEGRAND SA
FRA FRAPORT AG
LI KLEPIERRE SA
ALV ALLIANZ SE
ORSTED ORSTED
RAA RATIONAL AG
INGA ING GROEP NV
SAN BANCO SANTANDER S.A.
IHG INTERCONTINENTAL HOTELS GROUP PLC
MRNA MODERNA INC.
VWS VESTAS WIND SYSTEMS
UMG UNIVERSAL MUSIC GROUP NV
DSY DASSAULT SYSTEMES SA
DTG DAIMLER TRUCK
LIN LINDE PUBLIC LIMITED COMPANY
SHUR SHURGARD SELF STORAGE LIMITED
- Bruno Cavalier
- Jerôme Bodin
LR LEGRAND SA
FRA FRAPORT AG
LI KLEPIERRE SA
ALV ALLIANZ SE
ORSTED ORSTED
RAA RATIONAL AG
INGA ING GROEP NV
SAN BANCO SANTANDER S.A.
IHG INTERCONTINENTAL HOTELS GROUP PLC
MRNA MODERNA INC.
VWS VESTAS WIND SYSTEMS
UMG UNIVERSAL MUSIC GROUP NV
DSY DASSAULT SYSTEMES SA
DTG DAIMLER TRUCK
LIN LINDE PUBLIC LIMITED COMPANY
SHUR SHURGARD SELF STORAGE LIMITED
- Dominic Rose
- Naresh Chouhan
Sanofi - The Path to €120 (BUY, TP EUR120 [110], 7pgs)
This new analysis shows how Sanofi shares get to €120 (+c.30%) by end 2025. We have conducted a foundational analysis that investors can refer to over the next 18mths as Sanofi releases at least 15 P2 & P3 pipeline readouts. We show the upside potential from every single readout and show that just 4 drugs could add €18/share upon successful readouts. In addition to multiple readouts, the likely Consumer Health spin in Q4, the tolebrutinib overhang being resolved one way or another and a strong C...
Combined General Shareholders' Meeting of May 22, 2024: availability o...
Combined General Shareholders' Meeting of May 22, 2024: availability of preliminary documents Press ReleaseVELIZY-VILLACOUBLAY, France — May 3, 2024 COMBINED GENERAL SHAREHOLDERS’ MEETING OF MAY 22, 2024 Availability of preliminary documents (Euronext Paris: FR0014003TT8, DSY.PA) informs its shareholders that its Combined Shareholders’ Meeting will be held on Wednesday, May 22, 2024 at 3:00 pm at Dassault Systèmes’ headquarters, 10 rue Marcel Dassault – 78140 Vélizy-Villacoublay. The preliminary notification stating the agenda and the draft resolutions was published in the Bull...
- Benoit Valleaux
Allianz : Solid operating profit expected in Q1 2024
>We are forecasting Q1 2024 operating profit of € 3.9bn - Allianz is due to report its Q1 2024 results on 15 May. We are forecasting operating profit of € 3,886m (+4.2%), in line with the consensus (€ 3,897m, +4.4%e). Q1 operating profit should, in our view, confirm the fact that Allianz should report a full-year operating profit at the upper end of the guidance range (€ 14.8bn, +/- € 1bn, bearing in mind that 1/4 of the average point of the target range is equivalent...
- Benoit Valleaux
Allianz : Un RO solide attendu au T1 2024
>Nous prévoyons un RO de 3.9 Md€ au T1 2024 - Allianz publiera son RN du T1 2024 le 15 mai prochain. Nous prévoyons un RO de 3 886 M€ (+4.2%), en ligne avec le consensus (3 897 M€, +4.4%e). Le T1 devrait ainsi, selon nous, confirmer la capacité d’Allianz de publier un RO en année pleine 2024 dans le haut de la fourchette cible (14.8 Md€, +/- 1 Md€, sachant que 1/4 du point moyen de la fourchette cible équivaudrait à 3.7 Md€ de RO/trimestre en moyenne sur 2024). Pour r...
- Francesca Ferragina
Vonovia/Many positives on different fronts/BUY
We confirm our positive stance on Vonovia. FY24 has started well with a satisfying number of disposals and, more importantly, at prices substantially in line with latest valuations. Organic growth guidance has been marginally revised upwards and regulation uncertainties are removed at least until end-2025. The value decline continues to lose steam, and this is key for the LTV management and to start thinking about what comes next. We change our estimates only marginally and confirm our BUY ratin...
Nokia Corporation: Repurchase of own shares on 02.05.2024
Nokia Corporation: Repurchase of own shares on 02.05.2024 Nokia CorporationStock Exchange Release02 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 02.05.2024 Espoo, Finland – On 02 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL401,8253.45CEUX--BATE--AQEU--TQEX--Total401,8253.45 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to...
Bouygues - Monthly disclosure of the total number of shares and voting...
Bouygues - Monthly disclosure of the total number of shares and voting rights REGULATED INFORMATION MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Article 223-16 of the AMF General Regulation Date Shares Voting rights Theoretical (1) Exercisable (2) 30 Arpril 2024 379,068,826 493,403,695 492,047,125 (1) In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all the shares to which voting rights are attached, including shares for which voting rights have been suspended.(2) For info...
Bouygues - Publication mensuelle du nombre d'actions composant le capi...
Bouygues - Publication mensuelle du nombre d'actions composant le capital et du nombre total de droits de vote INFORMATION REGLEMENTÉE PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE Article 223-16 du Règlement général de l’AMF Date Nombre d’actions composant le capital Nombre total de droits de vote théoriques (1) exerçables (2) 30 avril 2024 379 068 826 493 403 695 492 047 125 (1) Conformément à l’article 223-11 du Règlement général de l’AMF, nombre calculé sur la base de l’ensemble des actions auxque...
Dassault Systèmes: disclosure of trading in own shares
Dassault Systèmes: disclosure of trading in own shares Press ReleaseVELIZY-VILLACOUBLAY, France — May 2, 2024 DISCLOSURE OF TRADING IN OWN SHARES(Repurchase program decided by the General Meeting of Shareholders of May 24, 2023) Issuer: (Euronext Paris: FR0014003TT8, DSY.PA)Type of securities: Ordinary sharesPeriod: April 26, 2024 Detailed information (presentation by day and by market and transaction-by-transaction details) can be consulted on the website of Dassault Systèmes: Presentation of the trading in own shares by day and by market Name of issuerIdentification code of the issu...
Press Release: Beyfortus real-world evidence published in The Lancet s...
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in infants during the 2023-2024 RSV season, versus no intervention1-6Results add to the consistent high efficacy of Beyfortus against medically attended RSV lower respiratory tract disease, shown in the pivotal clinical studies and the o...
Communiqué de presse : Des données de vie réelle concernant Beyfortus ...
Communiqué de presse : Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS Des données de vie réelle concernant Beyfortus publiées dans The Lancet montrent une réduction de 82 % des hospitalisations de nourrissons dues au VRS De nouvelles données de vie réelle montrent que Beyfortus (nirsevimab) a permis de réduire sensiblement les infections des voies respiratoires inférieures dues au VRS chez les nourrissons, de même que les hospitalisations, au cours de la saison virale 2023-2024, compa...
Sanofi: 1 director
A director at Sanofi bought 1,000 shares at 91.380EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
Nokia Oyj: Omien osakkeiden takaisinosto 30.04.2024
Nokia Oyj: Omien osakkeiden takaisinosto 30.04.2024 Nokia OyjPörssitiedote30.04.2024 klo 22.30 Nokia Oyj: Omien osakkeiden takaisinosto 30.04.2024 Espoo – Nokia Oyj (LEI: 549300A0JPRWG1KI7U06) on 30.04.2024 hankkinut omia osakkeitaan (ISIN FI0009000681) omistukseensa seuraavasti: Markkinapaikka (MIC Code)Osakkeiden lukumääräPainotettu keskihinta osakkeelta, euroa*XHEL398 8343,42CEUX--BATE--AQEU--TQEX--Yhteensä398 8343,42 * Kahden desimaalin tarkkuuteen pyöristettynä Nokia ilmoitti 25. tammikuuta 2024, että yhtiön hallitus on käynnistämässä osakkeidensa takaisinosto-ohjelman palauttaaksee...
Nokia Corporation: Repurchase of own shares on 30.04.2024
Nokia Corporation: Repurchase of own shares on 30.04.2024 Nokia CorporationStock Exchange Release30 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 30.04.2024 Espoo, Finland – On 30 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL398,8343.42CEUX--BATE--AQEU--TQEX--Total398,8343.42 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return u...
Dassault Systemes Sa: 1 director
A director at Dassault Systemes Sa bought 500 shares at 37.300EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Press Release: Annual General Meeting of April 30, 2024
Press Release: Annual General Meeting of April 30, 2024 Annual General Meeting of April 30, 2024 Approval of the financial statements for the fiscal year 2023Distribution of a cash dividend of €3.76 per share, with payment as of May 15, 2024Board composition: renewal of two Directors and appointment of three new Independent Directors Paris, April 30, 2024. The Combined General Shareholders’ Meeting of Sanofi was held on April 30, 2024, under the chairmanship of Frédéric Oudéa. All resolutions submitted to the vote were adopted by the shareholders. The General Meeting approved the indi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.